Tilray and SunOpta formed a strategic partnership to expand medical cannabis operations in Italy.
2 reports, 1 independent
Updated Aug 15
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tilray and SunOpta formed a strategic partnership to expand medical cannabis operations in Italy.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Tilray and SunOpta partner to expand medical cannabis presence in Italy.1 source
Strategic partnership between Tilray and SunOpta expands medical cannabis operations in Italy.1 source
Keep exploring
The entities involved
-
Tilray
pharmaceutical and cannabis company
-
Italy
country in southern Europe
-
SunOpta
Canadian food and mineral company
Nothing else this week.
Related events
- Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
- Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.
- Tilray launched new medical cannabis strains in Germany, aiming to improve access in Europe's largest market.
Coverage
Newest first; wire copies grouped- StockStorySunOpta, Tilray, Olaplex, Energizer, and Hain Celestial Shares Plummet, What You Need To Know A number of stocks fell in the afternoon session after markets pulled back amid hotter-than-expected infl
- StockStoryTilray (TLRY) Stock Trades Up, Here Is Why Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 18.9% in the morning session after it announced a strategic partnership to expand its medical